West Pharmaceutical Services Inc (WST)
316.59
-4.29
(-1.34%)
USD |
NYSE |
Nov 22, 16:00
316.53
-0.06
(-0.02%)
After-Hours: 20:00
West Pharmaceutical Services Free Cash Flow: 321.60M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 321.60M |
| June 30, 2024 | 357.10M |
| March 31, 2024 | 386.10M |
| December 31, 2023 | 414.50M |
| September 30, 2023 | 420.00M |
| June 30, 2023 | 396.80M |
| March 31, 2023 | 410.00M |
| December 31, 2022 | 439.40M |
| September 30, 2022 | 387.80M |
| June 30, 2022 | 401.50M |
| March 31, 2022 | 382.00M |
| December 31, 2021 | 330.60M |
| September 30, 2021 | 341.10M |
| June 30, 2021 | 287.40M |
| March 31, 2021 | 307.10M |
| December 31, 2020 | 298.10M |
| September 30, 2020 | 272.10M |
| June 30, 2020 | 277.40M |
| March 31, 2020 | 247.00M |
| December 31, 2019 | 240.80M |
| September 30, 2019 | 215.20M |
| June 30, 2019 | 200.70M |
| March 31, 2019 | 185.70M |
| December 31, 2018 | 183.90M |
| September 30, 2018 | 192.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 172.30M |
| March 31, 2018 | 166.30M |
| December 31, 2017 | 132.50M |
| September 30, 2017 | 104.80M |
| June 30, 2017 | 83.00M |
| March 31, 2017 | 68.40M |
| December 31, 2016 | 49.20M |
| September 30, 2016 | 48.10M |
| June 30, 2016 | 67.50M |
| March 31, 2016 | 77.10M |
| December 31, 2015 | 80.80M |
| September 30, 2015 | 76.30M |
| June 30, 2015 | 72.50M |
| March 31, 2015 | 61.40M |
| December 31, 2014 | 70.80M |
| September 30, 2014 | 78.20M |
| June 30, 2014 | 66.90M |
| March 31, 2014 | 84.60M |
| December 31, 2013 | 64.70M |
| September 30, 2013 | 74.80M |
| June 30, 2013 | 73.40M |
| March 31, 2013 | 31.20M |
| December 31, 2012 | 55.40M |
| September 30, 2012 | 26.20M |
| June 30, 2012 | 19.50M |
Free Cash Flow Range, Past 5 Years
240.80M
Minimum
Dec 2019
439.40M
Maximum
Dec 2022
345.92M
Average
349.10M
Median
Free Cash Flow Benchmarks
| Repligen Corp | 131.26M |
| Perspective Therapeutics Inc | -40.58M |
| Retractable Technologies Inc | -9.854M |
| Xtant Medical Holdings Inc | -17.28M |
| Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 180.10M |
| Cash from Investing (Quarterly) | -82.10M |
| Cash from Financing (Quarterly) | -64.40M |
| Free Cash Flow Per Share (Quarterly) | 1.346 |
| Free Cash Flow to Equity (Quarterly) | 102.00M |
| Free Cash Flow to Firm (Quarterly) | 98.80M |
| Free Cash Flow Yield | 1.37% |